| Dr Mary Person Garner, MD | |
|
600 Leigh Dr, Columbus, MS 39705-3014 | |
| (662) 327-7525 | |
| Not Available |
| Full Name | Dr Mary Person Garner |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 21 Years |
| Location | 600 Leigh Dr, Columbus, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437346962 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 19665 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastroenterology Associates Of Columbus, Pa | 2860450699 | 11 |
News Archive
Research shows that teenagers and adults with immune-mediated relapse after herpes simplex encephalitis rarely display the symptoms typically seen in children, delaying the initiation of vital immunotherapy.
Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.
Canadian researchers say that babies as young as 4 months of age know the difference between English and French by looking for visual cues.
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, Fundeni Clinical Institute (Romania) and Koen Kaen University (Thailand), have made a seminal breakthrough in understanding the molecular basis of bile duct cancer or cholangiocarcinoma, a rare but highly lethal form of liver cancer.
› Verified 5 days ago
| Entity Name | Gastroenterology Associates Of Columbus, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780753368 PECOS PAC ID: 2860450699 Enrollment ID: O20041228000150 |
News Archive
Research shows that teenagers and adults with immune-mediated relapse after herpes simplex encephalitis rarely display the symptoms typically seen in children, delaying the initiation of vital immunotherapy.
Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.
Canadian researchers say that babies as young as 4 months of age know the difference between English and French by looking for visual cues.
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, Fundeni Clinical Institute (Romania) and Koen Kaen University (Thailand), have made a seminal breakthrough in understanding the molecular basis of bile duct cancer or cholangiocarcinoma, a rare but highly lethal form of liver cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Person Garner, MD 850 Greenbriar Dr, Columbus, MS 39705-1462 Ph: (662) 386-0515 | Dr Mary Person Garner, MD 600 Leigh Dr, Columbus, MS 39705-3014 Ph: (662) 327-7525 |
News Archive
Research shows that teenagers and adults with immune-mediated relapse after herpes simplex encephalitis rarely display the symptoms typically seen in children, delaying the initiation of vital immunotherapy.
Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.
Canadian researchers say that babies as young as 4 months of age know the difference between English and French by looking for visual cues.
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, Fundeni Clinical Institute (Romania) and Koen Kaen University (Thailand), have made a seminal breakthrough in understanding the molecular basis of bile duct cancer or cholangiocarcinoma, a rare but highly lethal form of liver cancer.
› Verified 5 days ago